Leukotrienes and sex: Strange bedfellows?

Lewis J. Smith*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations


Leukotrienes are proinflammatory lipid mediators that have been shown to be upregulated in several diseases, including asthma, aspirinexacerbated respiratory disease (AERD), inflammatory bowel disease, and acute respiratory distress syndrome. Leukotrienes have been explored as therapeutic targets for these diseases and others; however, leukotriene inhibitors have had limited success in the clinic. There are noted differences in the incidence of leukotriene-mediated diseases in males and females, but sex as a factor in the response to leukotriene inhibitors has not been fully explored. In this issue of the JCI, Pace and colleagues present evidence that there are sex-specific differences in the effectiveness of certain leukotriene inhibitors and link the differences in response to the presence of androgens. The results of this study indicate that sex needs to be taken into consideration in the future evaluation of leukotriene inhibitors to treat disease.

Original languageEnglish (US)
Pages (from-to)2895-2896
Number of pages2
JournalJournal of Clinical Investigation
Issue number8
StatePublished - Aug 1 2017

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Leukotrienes and sex: Strange bedfellows?'. Together they form a unique fingerprint.

Cite this